SM-88

· Tyme, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SM-88, covering 2023-08-28 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma [Phase 2]